Using the largest database of real-time recordings of the effects of common and commercially available cannabis products in the United States, researchers at The University of New Mexico found strong evidence that cannabis can significantly alleviate pain, with the average user experiencing a three-point drop in pain suffering on a 0-10 point scale immediately following cannabis consumption.
Among adults aged 18 years and older, 31 percent used prescription opioids only as prescribed by a physician medically and 4 percent misused them. Thus, the overwhelming majority (88 percent) of all past-12-month prescription opioid users used the drugs for medical purposes only.
People who frequent electronic dance music (EDM) parties often use multiple drugs simultaneously and experience adverse effects with some ending up in the emergency department, say researchers at New York University School of Medicine and Rutgers University.
In a first-ever randomized trial, patients at a short-term inpatient program began long-term outpatient treatment with buprenorphine before discharge, with better outcomes than detox patients.
A research study into New Psychoactive Substances (NPS) -- formerly referred to as 'legal highs' -- provides new evidence about why young people were attracted to the drugs, and the health and social risks associated with taking them. The study was carried out by an interdisciplinary team of researchers from Queen's University Belfast. The research findings recommend support using existing evidence-based interventions among young people and high risk populations.
The prevalence of depression, cannabis use, and alcohol abuse increased among former smokers from 2005 to 2016 in the U.S., according to a new study by researchers at Columbia Mailman School of Public Health. Therefore, increases in these risk factors for relapse among former smokers could threaten progress in reducing the prevalence of cigarette use. This is the first national US study to focus on the prevalence and time trends of depression, marijuana use, and problematic alcohol use among former smokers.
A new study in the American Journal of Preventive Medicine, published by Elsevier, found that the prevalence of depression, cannabis use, and alcohol abuse increased among former smokers from 2005 to 2016 in the United States. Therefore, increases in these risk factors for relapse among former smokers could threaten progress in reducing the prevalence of cigarette use.
Heavy cigarette smokers with at least a 20 pack-year smoking history can reduce their risk of cardiovascular disease (CVD) by 39% within five years if they quit, according to a study published today in the Journal of the American Medical Association (JAMA).
A Penn study reveals single instance of vaping immediately leads to reduced vascular function.
An analysis of Framingham Heart Study data examined the association of the time between quitting smoking and new cases of cardiovascular disease (CVD). This analysis included nearly 8,800 individuals, including 2,371 heavy smokers who smoked 20 or more pack-years, which is equal to smoking one pack of cigarettes daily for 20 years.